Statistical issues in the assessment of health outcomes in children : methodological review. by Lancaster, Gillian
  
 




Gillian A Lancaster, PhD, CStat, Senior Lecturer in Medical Statistics and Director of 
Postgraduate Statistics Centre, Lancaster University, UK 
 
 
Address for correspondence: Dr G.A. Lancaster, Postgraduate Statistics Centre, Dept of 
Mathematics and Statistics, Lancaster University, Fylde College, Lancaster, LA1 4YF.  
Email: g.lancaster@lancaster.ac.uk, telephone: 01524 593943, fax: 01524 592681. 
Summary 
The lack of outcome measures that are validated for use on children limits the effectiveness 
and generalisability of paediatric health care interventions. Statistical epidemiology is a broad 
concept encompassing a wide range of useful techniques for use in child health outcome 
assessment and development. However the range of techniques available is often confusing 
and prohibits their adoption. In this paper an overview of methodology is provided within the 
paediatric context. It is demonstrated that in many cases assessment can be performed 
relatively straightforwardly using standard statistical techniques, although sometimes more 
sophisticated techniques are required. Examples of both physiological and questionnaire 
based outcomes are given. The usefulness of these techniques is highlighted for achieving 
specific objectives and ultimately for achieving methodological rigour in clinical outcome 
studies performed in the paediatric population. 
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The European Commission's proposal for a Regulation on Medicinal Products for Paediatric 
use (Commission of the European Communities, 2004) stated that ‘The paediatric population 
is a vulnerable group with developmental, physiological and psychological differences from 
adults, which makes age and development related research of medicines particularly 
important… more than 50% of the medicines used to treat the children of Europe have not 
been tested and are not authorised for use in children: the health and therefore the quality of 
life of the children of Europe may suffer...’ In the EU, the paediatric population (0-16 years) 
represents about 75 million people, that is 20% of the total population.  
 
Child health outcome assessment can be defined as the procedures used to describe and 
quantify the effectiveness of all paediatric health care interventions including medicines. In 
this respect we want to be able to distinguish between positive and negative effects of 
treatment and quantify the magnitude of these effects. Ethical issues of research involving 
children (Helseth and Slettebo, 2004) emphasise the importance of assessment and 
quantification of health outcomes in the paediatric population. However, the lack of outcome 
measures that are validated for use on children limits the generalisability of treatment 
effectiveness results (Patrick and Chiang, 2000). In this paper we describe the main issues to 
consider in health outcome assessment during the process of development, illustrate various 
measurement methods using examples taken from different paediatric contexts, and highlight 
the appropriate statistical tools to use in each case. The emphasis is on providing an overview 
of the process to give researchers a context within which to work and with useful references 
for further study of specific techniques. 
 
Paediatric assessments are derived from several sources. They may be based on child-reported 
outcomes, for example, pain measurement in children as young as 3 years old using smiley 
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faces (Wong and Baker, 1995), or parent or caregiver-reported outcomes, for example, to 
assess burden of care (Glasscoe et al., 2006a) or perceived Health Related Quality of Life 
(HRQL) (Eiser and Morse, 2001a). The use of proxy respondents prompts much debate in the 
literature (Eiser and Morse, 2001b, Janse et al., 2004) but may help to limit missing data when 
evaluating treatment over time for those unable to participate. Clinician or assessor-reported 
outcomes include physiological or pathological measures, for example, Body Mass Index 
(BMI) (Cleary et al., 2004), white cell count (Farrell et al., 2002), perceived pain (Stewart et 
al., 2004) or survival (Wong et al., 2000). Data may be collected in a variety of ways, for 
example, from medical records, laboratory reports or by direct observation and measurement, 
or through interviews, self-administered questionnaires and daily diaries.  
 
All forms of assessment such as diagnostic and laboratory testing and psychometric testing, 
require instruments that have been shown to be reliable and valid (Gnecco and Lachenbruch, 
2002). In this paper we are using the term ‘instrument’ to refer to any measuring device 
whether a mechanical device or a questionnaire. Development of measurement instruments is 
discussed in Section 2, and issues concerning reliability and validity of measurement in 
Section 3. A useful instrument should also be able to demonstrate that it can detect changes in 
a health outcome over time within subjects, and also distinguish or discriminate between 
subjects on the scale of interest (Guyatt et al., 1987, Chwalow and Adesina, 2002), and these 
issues are discussed in Section 4. The establishment of reference values for healthy children 
in the population of interest is another important aspect of instrument development (Jones et 
al., 1993, Marquis et al., 2004) that is addressed in Section 5. Some further considerations are 
given in the discussion in Section 6. 
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2. Development of a new instrument 
There are several stages to go through in developing a new instrument and in demonstrating 
its reliability and validity, and therefore several phased studies (Asmussen et al., 1999) are 
usually required. The main stages in the development and assessment of a health outcome 
measure are summarised in Table 1. 
Physiological measurement devices 
If a new physiological measuring device has been developed and put on the market, for 
example, for measuring a child’s blood glucose level or temperature, then it would be of 
interest to compare the performance of this device to one in current use, to consider its 
potential for adoption in practice. The new procedure may be less costly or painful, or the 
standard device too invasive to use in young children. A method comparison study can be 
carried out to determine whether the new method agrees sufficiently well with the reference 
standard. Bland and Altman (1999) have published a well-known methodology for 
quantifying systematic error (bias) and random error (limits of agreement), assuming that the 
measurements are recorded on the same continuous scale. If repeated measurements or 
replicates are available then methods based on Analysis of Variance (ANOVA) (Bland and 
Altman, 1999), confirmatory factor analysis (Dunn, 1992) or multi-level modelling (Snijders 
and Bosker, 1999) can separate out the different sources of variability. When the two 
measurements have not been recorded on the same scale then regression modelling can be 
used to calibrate one set of values to the same scale as the other set, provided that an estimate 
of repeatability is available from the same or a comparable sample (Chinn, 1990, Dunn and 
Roberts, 1999). Cohen’s kappa (Cohen, 1960) is a popular measure of agreement for binary 
and ordinal data, which is discussed further in section 3. 
 
Method comparison studies are closely related to diagnostic test studies in terms of study 
design but enable more detailed preliminary evaluation to determine whether the methods 
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agree with each other across the whole spectrum of the measurement scale, or whether they 
do not agree but relate to each other by a constant amount above or below the other (Craig et 
al., 2002). In a diagnostic test study the new method is evaluated against a given single 
threshold or cut-off, and the second possibility cannot then be examined. In diagnostic test 
studies we are interested in establishing the sensitivity and specificity of the test compared to 
a gold standard criterion (see also Table 1), classifying for example whether a child is 
diseased or not diseased, and this type of study design and analysis is well documented in the 
literature (see for example Pepe (2003)). Prospective recruitment of children from the target 
population as a consecutive or random sample ensures measurements are taken across the 
whole spectrum of the disease. An alternative case-control approach has been shown to inflate 
estimates of sensitivity and specificity and test performance (Lijmer et al., 1999), because it 
concentrates only on the extremes of the sample (known cases and controls) and may not 
cover the middle of the spectrum. Altman (1991) gives guidelines for sample size for method 
comparison studies, NQuery Advisor 5.0 (Elashoff, 2003) is able to calculate sample sizes for 
confidence interval estimation of the kappa statistic, and sample size considerations for 
diagnostic test studies is given in Freedman (1987) and by Zhou et al. (2002).  
 
In general, the methodological quality of these types of studies has been found to be lacking, 
particularly in children (Craig et al., 2000, Farrell et al., 2002). Common misconceptions 
included the use of correlation rather than agreement to compare the two methods, very small 
sample sizes that were boosted by including repeated measurements on the same individuals 
in the sample as independent observations, ignoring within-person correlation, and poor or no 
description of the procedural methods used to control for bias. Criteria for assessing 
methodological quality in these types of studies are given in Craig et al. (2000) and a 




When the instrument takes the form of a questionnaire, the first stage of development is quite 
often the creation of questions or items through the use of focus groups and qualitative 
interviews with children or parents and carers (a topic in itself) to identify for example, the 
impact of caring for children with cystic fibrosis (Glasscoe et al., 2006a, Glasscoe et al., 
2006b). The instrument may also be shown to users and experts to establish face and content 
validity. For example, in the development of a culturally appropriate developmental 
assessment tool for use on children in Malawi (Gladstone et al., 2008), problematic items 
were re-adapted or re-translated after cursory review by eight local research workers, five 
Malawian paediatricians, six medical students and a language expert from the University of 
Malawi. In later stages of development the instrument is piloted on a small sample of children 
or carers with preliminary evaluation of item performance. Item performance evaluation 
identifies mean, minimum and maximum responses, percentage missing, floor and ceiling 
effects (where majority of responses fall in lowest/highest category) and item-total 
correlations (Streiner and Norman, 2003). Optimal item performance occurs with large 
response ranges, few missing data and low percentages of minimum and maximum values 
(Asmussen et al., 1999, Kleinman et al., 2006). 
 
In the paediatric context there are issues to address regarding the changing developmental 
status of a child. In particular, development of a carefully designed age-related instrument, 
incorporating the correct level of language comprehension with age-appropriate instrument 
formatting and design will minimize the likelihood of ‘response sets’. The term ‘response set’ 
means that a child will respond in a certain type of way regardless of what is being asked, for 
example, through repetitive responses, or to please the interviewer or appear competent 
(Matza et al., 2004). However, an approach that addresses developmental status by using age-
specific instruments poses a problem when measuring change over time, particularly in 
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consistency and context of measurement (see ‘Measuring Health Related Quality of Life’ in 
Section 4). Problems of translation have also been highlighted (Wittes, 2002), with scores on 
a measure of verbal fluency being affected by the range of vocabulary available within the 
different languages of the countries taking part in the trial. Whilst this example was based on 
an adult sample it does have similar implications for instrument development in children.  
 
3. Establishing the reliability and validity of measurement 
Reliability is concerned with the consistency of measurement, whether measurements are 
made by the same person on different occasions or different people on the same occasion, and 
validity is concerned with the accuracy of measurement and whether an instrument is actually 
measuring what it is supposed to be measuring. If an instrument exists but has never been 
used in a certain paediatric population, or has been adapted from adult studies, then it is 
important to establish that it is reliable and valid for use in that population before applying it 
in an intervention study. For example, an instrument that is reliable and valid in a clinic 
setting may be neither reliable nor valid in the community or hospital. Validity and reliability 
are therefore not fixed, immutable properties of an instrument but rather an interaction 
between the instrument and group completing it, and these properties may vary from one 
situation to another. Some attempts have been made to assess an instrument from within an 
intervention study. However, this has the potential for inflating false positive error rates, as 
well as a lack of reproducibility and generalisability to a more heterogeneous patient group to 
which the intervention would be applied in practice (Gnecco and Lachenbruch, 2002). It also 
runs the risk of conducting much of the study before discovering that the instrument is not 
valid or reliable.  
Reliability 
A reliable instrument is one whose scores shows stability and consistency of measurement 
when used by the same assessor on two separate occasions (intra-rater/test-retest reliability) or 
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different assessors on the same occasion (inter-rater reliability). Here we are interested in the 
accuracy of measurement in relation to the likely range of values of the instrument, for 
example for detecting wheeze in infants (Powell et al., 2002). Reliability is most commonly 
expressed as a ratio of the variability between individuals to the total variability in the 
measurements, which is the variability between individuals plus measurement error. This is 
called an intra-class correlation coefficient (ICC) and can be calculated easily using ANOVA 
(Streiner and Norman, 2003) or multilevel modelling (Snijders and Bosker, 1999). It is not a 
fixed characteristic and can change with the prevalence of the condition being studied 
between populations of children (Dunn, 1992), see for example Feeny et al.’s (2004) teenage 
comparisons using the health utilities index mark 2 (HUI2) and HUI3 scores. There has been 
much debate as to the most appropriate choice of reliability co-efficient. In particular, 
Cohen’s kappa (Cohen, 1960) is often used to measure agreement in the medical literature 
(Powell et al., 2002, Elphick et al., 2004, Stewart et al., 2004), however if a quadratic 
weighting scheme is used, it can be shown to be exactly identical to an ICC (Fleiss and 
Cohen, 1973). It too is affected by prevalence. A generalised kappa statistic has been 
proposed for assessments made by multiple (>2) raters (Fleiss et al., 2003). The constraint 
underlying kappa, is that the probability of positively rating inconclusive items (random 
ratings) is equivalent to that for rating conclusive items (systematic ratings). When this 
constraint is violated then latent class analysis (Guggenmoos-Holzmann and Vonk, 1998) 
provides a more general framework within which to work. In general ICCs are used for 
continuous data and kappas for binary or categorical data. The design and analysis of 
reliability studies is discussed in Dunn (1992, 2000), and the ICC, kappa statistic, Pearson’s 
product-moment correlation coefficient and Bland and Altman’s method have been compared 
by Streiner and Norman (2003). 
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In diagnostic and laboratory tests that measure physiological outcomes, when a gold standard 
exists the rationale for the new instrument may be that the existing test is expensive or time-
consuming to administer. When a gold standard is not available then assessment of agreement 
between devices can still be made. For example, Elphick et al. (2004) demonstrated the 
unreliability of the stethoscope for assessing respiratory sounds in infants, which had 
important implications for its use as a diagnostic tool for lung disorders, but equally they were 
unable to assess the reliability of acoustic analysis as an alternative diagnostic procedure 
because of the lack of a reliable gold standard.  
 
In questionnaire-type measures, the instrument needs to have good internal properties for it to 
be of use in practice. As part of the reliability study therefore, item performance should be re-
evaluated in this larger sample. Internal reliability should then be established, particularly if 
multiple items are contained within several domains. Internal reliability (Asmussen et al., 
1999, Powell et al., 2002, Kleinman et al., 2006) can be assessed using several methods, for 
example, Cronbach’s alpha, a split-half coefficient or the Kuder-Richardson 20 method 
(Streiner and Norman, 2003), all of which can be computed in standard statistical software. A 
factor analysis will help to determine the internal structure of the instrument by establishing 
the number of domains that are being measured and identifying redundant items (Powell et 
al., 2002). Item response analysis may be usefully applied to categorical or ordinal data 
(Drachler et al., 2007), and further information about factor analysis of binary and ordinal 
data (and mixtures) can be found in Bartholomew et al. (2008). Estimation for the methods 
can be carried out using Mplus (Muthén and Muthén, 1998-2007) or Stata (via GLLAMM) 
(Skrondal and Rabe-Hesketh, 2004). However, these types of analyses are not always 




A valid instrument is one which measures what it purports to be measuring in a particular 
group of children, for example, pain intensity in young children using smiley faces (Wong 
and Baker, 1995) or HRQL using the PedsQLTM 4.0 (Pediatric Quality of Life InventoryTM) 
(Varni et al., 2003). Construct validity, a term that subsumes the various components of 
validity, is the focus here and refers to the extent to which the instrument conforms to the 
predicted theoretical properties that would be expected in its field of application. Convergent 
validity, for example, is demonstrated if the instrument correlates well with other known 
constructs to which it should be related, such as the correlation of the PedsQLTM school 
functioning scale with achievement scores. Conversely, divergent (or discriminant) validity is 
demonstrated if the instrument does not correlate well with unrelated constructs that should 
show no association. Construct validity can also be tested by comparing the instrument in 
different settings, either on two extreme groups of children, for example, those with and 
without pain, which is called extreme groups construct validity, or on several known 
diagnostic groups with varying levels of pain, for example, mild pain (minor head injury), 
moderate pain, or severe pain (compound displaced forearm fracture) which is called known-
groups construct validity (Stewart et al., 2004). In this example assuming continuous data, 
significant differences between ordered diagnostic groups were tested using Cuzick’s test for 
trend (Cuzick, 1985). Criterion validity, another type of construct validity, is demonstrated by 
comparing the new instrument to an external criterion, ideally a gold standard, well-
established outcome, to demonstrate that the new instrument is both sensitive and specific in 
its diagnosis (see also diagnostic test studies in Section 2). There are two types of criterion 
validity, namely concurrent and predictive, with each defined according to how the external 
criterion is measured. For concurrent validity both the instrument and external criterion would 
be applied blind to the results of the other and measurements taken concurrently or 
immediately sequentially. For predictive validity the same principles of blinding should be 
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applied but in this case the external criterion will only become known, and measured, 
sometime in the future, for example after treatment or a biopsy, thus determining the 
usefulness of the instrument for predicting a likely outcome. In our pain example the external 
criterion might be level of analgesia (Stewart et al., 2004) or depth of burn wound (Beyer, 
1998) following clinical examination or surgery. Another type of validity, respondent validity, 
may also be carried out at the end of the study to provide an assessment of the impressions of 
the users of the instrument.  
 
Validating psychological measurements 
Measures for assessing child mental health generally come in the form of questionnaires, 
sometimes delivered by trained interviewers. The assessments may require repeat visits by the 
parent and child increasing the likelihood of missed visits due to work commitments or an 
upset child. The assessments may be designed for use on adults and use language that is too 
difficult for a child to comprehend, or there may be no gold standard criterion available for 
use on children. In addition interviews are often time consuming and a child may not be able 
to tolerate too many questions.  
 
The use of multiple respondents to validate responses in this context has been advocated as a 
better predictor of disorder (Young et al., 1987), although the agreement between child and 
parent in structured interviews has been shown to vary depending on type of disorder, with 
more agreement for behavioural symptoms, and less for anxiety (Hodges, 1993). In the 
Mental Health Survey of Children and Adolescents in Great Britain (Meltzer et al., 2000) for 
example, a range of assessment methods were utilised. Face to face interviews helped 
diagnose depression, anxiety, hyperactivity and conduct disorders, whilst self-completion 
questionnaires solicited information on the use of cigarettes, alcohol and drugs. In addition, 
some questionnaires such as the Strengths and Difficulties Questionnaire (SDQ), were 
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completed by parents, teachers and children aged 11-15 years for cross-informant 
comparisons. A powerful technique for assessing convergent and discriminant validity 
together, particularly with multiple informants is the multitrait-multimethod matrix (Streiner 
and Norman, 2003). Here two or more different traits (eg. childhood anxiety and depression 
(Cole et al., 1997)) are each assessed by two or more measurement methods (eg. parent, 
teacher, peer) and a correlation matrix is derived using confirmatory factor analysis. High 
cross-method, within trait correlations are evidence of convergent validity and low 
correlations (within-method, cross-trait and cross method, cross-trait) are indicative of 
discriminant validity (Dunn, 2000). 
 
Many psychometric measures are designed for adults and require answering complex 
questions that a child may not understand. The Fairy Tale Test (Coulacoglou, 2002) is a novel 
way of rating, for example, fear of aggression, anxiety, or self-esteem in a quantitative 
manner from story-telling that has been standardised for use with 7-12 year olds. The use of 
doll role-play (Emde et al., 2003) is a similar approach that has been advocated to better 
understand a child’s beliefs, experiences and personality. This approach has been used for 
separating out hypothesised constructs such as avoidance or aggression from children with 
behavioural difficulties (Hill et al., 2007). Relating psychological well-being to physiological 
changes is another way of validating psychological measurements when this is possible. For 
example, elevated salivary cortisol has been positively correlated with externalising behaviour 
and negatively correlated with internalising behaviour in boys (Zaslow et al., 2006). It has 
also been associated with aggression and poor self-control, and with the amount of 





4. Measuring change over time and discriminating between subjects 
Since the goal of a treatment or intervention is to effect change in health status, then a useful 
instrument should be able to demonstrate change both within and between children. Yet this is 
one of the least studied areas in instrument development (Chwalow and Adesina, 2002). 
Evaluation of responsiveness over time within an individual might concern the measurement 
of pain or neurological functioning, for example, whereas measures that discriminate between 
children might focus on a child’s height or intelligence (Guyatt et al., 1987). Instruments of 
measurement come in many different forms as do their scoring systems. Instruments that 
measure physiological measurements such as blood pressure or temperature, use scales (eg. 
mmHg or Celsius) that have well-known interpretative clinical meaning. For example, fever is 
often defined as a temperature greater than 38oC (Dodd et al., 2006). With psychological 
instruments it is more difficult to determine what constitutes a meaningful change on the 
rating scale, and definitions of success can therefore be quite arbitrary, for example, a two-
point change from baseline (Marquis et al., 2004). It is only with experience that meaningful 
magnitudes of change or cut-offs can be established for these types of instruments.  
Magnitude of change and measurement error 
Responsiveness to change may be viewed as a longitudinal type of construct validity, 
involving assessment of change within individuals and interpretation of meaning (Patrick and 
Chiang, 2000). Three measures are commonly used to estimate the magnitude of change from 
baseline to end point or pre-test to post-test (eg. Kleinman et al., 2006); Cohen’s effect size 
(Cohen, 1988), Guyatt’s responsiveness statistic (Guyatt et al., 1987) and the standard error of 
measurement (Wyrwich et al., 1999) (or variations on this approximately equivalent to the 
minimum important difference). However, measures based on change scores are only 
appropriate when the between-subject variance exceeds the within subject variance which is 
equivalent to an ICC≥0.5 (Streiner and Norman, 2003). Moreover, to reduce problems with 
regression to the mean caused by overly high (or low) pre-test scores, then Analysis of 
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Covariance (ANCOVA) provides a more robust analysis for adjustment of pre-test 
measurements (Vickers and Altman, 2001). 
 
In clinical trials the primary interest is in what constitutes a clinically important difference, 
since changes may occur simply because of receiving attention, the Hawthorne effect, 
increasing knowledge, and measurement error. The Hawthorne effect is a well-known 
phenomena whereby participants in a trial have a better end result simply because of the effect 
of knowing that they are being studied, and dates back to studies done in the 1920s at the 
Western Electric Company’s Hawthorne plant near Chicago. Therefore changes that exceed 
these types of variability are most important and as the variability increases larger treatment 
effects are needed to discriminate between treatment groups and demonstrate efficacy (Guyatt 
et al., 1987). Measurement error is a problem particularly apparent in dietary outcome 
assessment, for example, to measure energy intake or nutritional status after administering 
protein energy supplements to children with cystic fibrosis (Poustie et al., 2006). Multiple-day 
food records or 24-hour dietary recalls are commonly used as reference instruments to 
calibrate food frequency questionnaires (FFQs) and to adjust findings for measurement error 
(Kwiterovich et al., 1997). Biomarkers for energy (doubly labelled water) and protein (urinary 
nitrogen), for example, may also be used to calibrate measures, but these are limited, costly 
and may cause inconvenience. Correct adjustment requires that the errors in the adopted 
reference instrument be independent of those in the FFQ and of true intake (Kipnis et al., 
2003). A novel approach used household itemised till receipts to calibrate dietary intake 
(Ransley et al., 2001), which proved an effective substitute for biomarkers (Greenwood et al., 
2006). When assessing dietary interventions in children pilot studies are recommended to 
ensure the acceptability of the intervention (Lancaster et al., 2004). They are also helpful in 
determining the choice of appropriate instrument for assessing change, particularly when 
children are neurologically impaired (Bassi et al., 2004). 
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Multiple measurements over time 
When multiple measurements are taken over time data analysis methods should address the 
longitudinal nature of the data and it is most efficient to use information at all time points to 
maximise the potential of the data without loss of information. However in clinical studies, 
sometimes to avoid the complexity of these types of analyses or because of missing data, the 
analysis may be restricted to two time points (baseline and the follow up time of primary 
interest), or a summary measure approach adopted to reduce the multiple measurements to 
one per child (Matthews et al., 1990). This may discard important information about trends 
within children or between groups of children. Questionnaire instruments often comprise of 
items that are rated on a Likert scale with 0 indicating no problem and 4 serious problems, for 
example. The analysis of ordinal data generated from questionnaire instruments rated on a 
Likert scale should be analysed using methods of ordinal longitudinal data analysis (Vermunt 
and Hagenaars, 2004). To overcome this level of complexity, ordinal data may be transformed 
from a Likert scale onto a common continuous scale ranging from 0-100 as in the PedsQLTM 
4.0 (Varni et al., 2003) and thus enable analysis by statistical methods for continuous data. 
Ordinal data may sometimes be dichotomized into a binary variable with 0 indicating no 
problem and 1 any type of problem, but this may result in the loss of a rich source of data 
about the spectrum of severity of the problem and statistical power. Choosing the right 
analysis strategy is therefore challenging. 
 
Growth curve modelling (Singer and Willett, 2003) is a type of longitudinal data analysis, that 
allows for non-linear change, which is likely to be pertinent for children. Longitudinal data 
can be viewed as a hierarchical two-level structure with the measurements made over time at 
level 1 and children at level 2. Then adopting a multi-level mixed modelling approach, the 
level 1 model captures within-person change and the level 2 model between-person change. In 
this respect growth curve models are a special case of general mixed models, in which a 
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subject-specific trajectory is defined by allowing both a random intercept and random slope 
with time (or age) as the predictor variable. For example, DeLucia and Pitts (2006) studied 
the impact of growth over time in emotional autonomy from mothers in the development of 
adolescents with spina bifida. The models can incorporate higher order growth parameters for 
non-linear trajectories, and are estimated directly, using routines available in standard 
statistical software such as SAS or STATA. 
 
As mentioned above, missing data are an additional burden when multiple measurements are 
taken. It is important therefore, to review the reasons for missingness (Fairclough, 2004). This 
will help determine whether certain domains are more difficult to measure than others, 
providing an indication that different methods of assessment may be required. Strategies for 
handling missing data are also important and necessary for minimising selection bias (Coste 
et al., 1995). For example, if it can be assumed that the data are missing completely at random 
(MCAR), that is, that there is no difference between children with observed scores and those 
with missing scores such that the missing assessments are unrelated to the outcome, then the 
missing data are ignorable. However, it may be more likely that the data are missing not at 
random (MNAR) and were caused by dropout due to severity of disease (ie. dropout is related 
to the unseen responses after dropout), then the missing data are non-ignorable, and more 
sophisticated methods of analysis, such as the use of pattern mixture models (Parsons et al., 
2006), are required to obtain unbiased estimates. The less restrictive missing at random 
(MAR) assumption assumes dropout is only related to responses made at any occasion prior 
to dropout (Schafer and Graham, 2002), and is the basis for many statistical methods for 
adjusting for missing data. Note that under this assumption using growth curve modelling 
within a multi-level modelling framework, children with missing responses can be included 
without further adjustment. If multiple imputation is used to impute missing values (Carpenter 
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et al., 2006), then the imputation model should account for correlation of the responses from 
the same subject. 
Measuring Health Related Quality of Life 
Measuring HRQL over time is more complex in paediatric studies than for adult studies, 
because children will vary in their stages of development. This has prompted the adoption of 
multiple age-specific forms for use on children. However, these may compromise the stability 
of the HRQL outcome when taking measurements over time and need to be carefully 
developed and tested, see for example, the PedsQLTM 4.0 (Varni et al., 2007) and work on 
health utility measures (Juniper et al., 1997, Feeny et al., 2004). Most HRQL findings to date 
have focused on cross-sectional studies, but as this field continues to evolve and instruments 
are used more routinely in clinical trials, then more literature in this area should begin to 
emerge (Landgraf, 2005). Moreover, it has been argued that the experiences and health 
concepts that a child can comprehend will not only be related to their age but also to their 
social context involving family, peer-relationships and community factors (Pal, 1996, 
McNunn et al., 2001). This may include the impact of the child’s treatment on the HRQL of 
the care-giver (Clarke and Eiser, 2004). This view is upheld by the World Health 
Organisation Quality of Life Assessment Group (1996) who also include the cultural 
perspective in their definition of HRQL. It is an important consideration since whereas adults 
have a choice as to whether they change their environment, children have less power to 
change a problematic situation. Another issue is the youngest age at which children can 
reliably report their HRQL, and when proxy respondents such as the parent, carer or doctor 
should be used (Janse et al., 2004). Eiser and Morse (2001b, 2001c) found greater 
heterogeneity in measures of social and emotional compared to physical functioning between 
parents and children and advocated the use of parallel forms for completion by both child and 
parents whenever possible until there is more conclusive evidence as to which informant is 
more reliable. It may be that the different perspectives of the parent/carer and the child 
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interact in some way such that cross informant discrepancies may have important HRQL 
significance. 
 
The appropriate choice of outcome from questionnaire items and subscales is an added 
complexity. Poor item performance may reduce the instrument’s effectiveness. Multiple 
testing of many items can result in inflated Type I errors, and combination of subscales can 
affect statistical efficiency in terms of relative effect size (Vickers, 2004). Wittes (2002) also 
identified problems of scaling in multidimensional instruments such that some parts of the 
instrument may contribute to the total score much more heavily than others creating 
imbalance and therefore a biased outcome. Sometimes for this reason global summary scores 
may be adopted. With child/carer-reported outcomes such as HRQL, an external criterion 
such as death or disease severity may be brought in to help interpret the magnitude of change, 
for example, survival with HRQL assessment (Patrick and Chiang, 2000). However, Patrick 
and Chiang question the extent to which statistical methods for combining outcomes to obtain 
a net measure of effectiveness are successful, particularly in validation and interpretability, 
and this needs further debate. 
 
5. Reference values 
The availability of reference values (or ‘norms’) for comparison with measured physiological 
values, for example, serum immunoglobulin concentrations in pre-school children (Altman, 
1991), and established ‘cut-offs’ for identifying conditions such as fever in infants (Jones et 
al., 1993, Dodd et al., 2006) is an essential requirement in clinical studies. The need for 
comprehensive interpretation strategies when using questionnaire-based rating scales has 
already been highlighted (Marquis et al., 2004). An instrument result is therefore not 
clinically meaningful or useful if appropriate data for comparison are not available. In their 
review of child outcome measures used in child care quality research, Zaslow et al. (2006) 
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describe ten methodological concerns, highlighting that many instruments were not 
established measures, which makes it difficult to clearly relate the content and gauge the 
strength of the measures across studies. They also highlighted poor reporting of validity and 
reliability information either in general or for an adapted instrument or in the culture in which 
the instrument was applied. 
 
To obtain reference data in the simplest case, the instrument is applied to a large sample of 
healthy children, and the mean and standard deviation are used to calculate a 95% reference 
interval, containing the middle 95% of the distribution of values found in healthy individuals. 
However, it is important to remember that a result outside the corresponding health-related 
reference interval does not necessarily imply that the child is diseased or at risk. This simple 
approach assumes that the data are normally distributed, or that a suitable transformation will 
create the desired effect. Since children vary in their stages of development, results are often 
dependent on age and gender, and so it may be necessary to have separate reference intervals 
for different age and gender groups. If data are not normally distributed then percentile 
values, usually the 2.5th and 97.5th centiles, can be calculated directly without any 
distributional assumptions (Altman, 1991). Examples of reference ranges in paediatric 
rheumatology are given in Nugent et al. (2001). Large numbers are required for these types of 
studies with the minimum number needed generally at least 500. Bland (2000) gives more 
information on sample size calculation. Alternative questionnaire-type approaches have used 
logistic regression to develop reference values for assessment tools. Gladstone et al. (2008) 
examined a range of developmental items (assessed as ‘pass’ or ‘fail’) using logistic 
regression and, for badly fitting models, triple fit spline regression (Greenland, 1995) to 
establish norms for the age at which 25%, 50%, 75% and 90% of children in Malawi passed 
that item. Figure 1 shows how useful plots of the model fits were for judging item 
performance. However, sometimes more sophisticated methods may be warranted. For 
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example, in revising the scoring system for the Griffiths assessment tool (Luiz et al., 2006), 
age-specific reference values (created in the original manual using simple linear regression) 
were more precisely constructed using the LMS method, described below. 
 
For population-based assessment, typically in nutritional surveillance, the z-score is widely 
recognized as the best system for analysis and presentation of anthropometric data because of 
its advantages compared to other methods. In the WHO global database on child growth and 
malnutrition (de Onis and Blössner, 2003), for example, weight-for-height, height-for-age and 
weight-for-age are interpreted by using the z-score classification system. The anthropometric 
values are expressed as a number of standard deviations or z-scores below or above the 
reference mean (or median) value for the age and gender. The scale is linear and a fixed z-
score interval implies a fixed height or weight difference for children of a given age and 
gender, making results comparable across groups. A major advantage is that a group of z-
scores can be subjected to summary statistics such as the mean and standard deviation to 
compare and contrast children’s growth status between groups.  
 
BMI is a common measure of weight adjusted for height that may be used to diagnose 
overweight and obesity (Duran-Tauleria et al., 1995), or to assess poor nutritional status 
(Cleary et al., 2004), and has been shown to have a U-shaped association with death (Wong et 
al., 2000). Although it has been criticised because it does not distinguish overweight due to 
excess fat mass from overweight due to excess lean muscle mass, it does correlate with more 
direct fat measures and is the most commonly used measure for use in screening large 
populations (Must and Anderson, 2006). BMI z-scores are measures of relative weight 
adjusted for a child’s age and sex, and are useful for measuring change over time. Because 
data in children are usually skewed, the International Obesity Task Force (Cole et al., 2000) 
used the LMS (Lambda, Mu, Sigma) method developed by Cole and Green (1991) to create 
 21
BMI z-scores. This is actually a special case of a more generalised additive approach (Rigby 
and Stasinopoulos, 2005), that also incorporates fractional polynomials (Royston and Wright, 
1998). Other anthropometric measures such as waist circumference, have been advocated in 
addition to BMI, particularly as the waist circumferences of British children increased more 
than their BMI from 1987 to 1997, suggesting that BMI alone may not provide the full picture 
in relation to changes in body composition and obesity-related health (Must and Anderson, 
2006). 
Collecting reference data from hard to access populations 
In general population studies it is sometimes difficult to find the subjects of interest because 
of the sensitivity of the topic, for example, child sexual abuse, or because an accurate 
diagnosis requires a detailed interview, as when measuring depression or parental neglect. 
The choice of using interviewer-based techniques as opposed to postal self-completion 
questionnaires has resource implications as well as issues of data quality. Interviewer-based 
questionnaires are costly and time-consuming to conduct but may obtain more detailed 
information, whilst postal questionnaires are cheaper at the risk of some inaccuracy or 
misinterpretation. Two-phase study designs (Dunn et al., 1999) have been advocated as a way 
of reducing interviewer costs. In the first phase of the study an initial screen of a large sample 
of the population is made utilising one or more postal questionnaires. In the second phase, the 
results of the first phase are used to stratify the subjects, then subsamples are taken from each 
strata and used for more detailed assessments involving an interviewer. By incorporating 
probability sampling weights reference value estimates can be calculated for the general 
population sample using the smaller stratified sample from the second phase (Thompson et 
al., 2001). However, this may cause difficulties if the screening questionnaire and interview 
methods are thought to measure different constructs. For example, in the Wirral Women’s 
Health Survey, parenting style was measured by a postal screening questionnaire, and then a 
smaller stratified sample had a detailed interview by a trained expert to measure parental 
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neglect (Hill et al., 2001). As a consequence it was of interest to see whether the two methods 
were measuring the same underlying construct of parental neglect (Lancaster et al., 2007). 
 
6. Discussion 
In this paper we have attempted to take the reader through the myriad of methods, procedures 
and study designs necessary for development and assessment of efficient child health outcome 
measures. We have highlighted through examples the usefulness of these procedures for 
achieving specific objectives, and ultimately for achieving methodological rigour in clinical 
outcome studies performed in the paediatric population. We have also highlighted specific 
child related problems requiring special consideration. 
Child Mental Health 
Child mental health can often be overlooked when assessing child health outcomes, with most 
attention given to quality of life and quality of care. Yet children with chronic disease and 
disability have increased susceptibility to psychiatric disorder and social adjustment problems 
(Cadman et al., 1987). Psychiatric disorders and abnormalities of emotions, behaviour or 
hyperactivity are present in approximately 10% of children and adolescents in the general 
population (Meltzer et al., 2000). We have already seen some of the difficulties of making 
psychological assessments in a general paediatric context, and in child mental health the 
problems are compounded, particularly since the majority of children in the community with 
disorders are not under the care of psychiatric services (Rutter et al., 1970) and therefore need 
to be identified from within the general population before they can be studied.  
 
In their review of outcome measures for child and adolescent mental health services, Hunter 
et al. (1996) found that the majority of outcome measurement tools understandably focused 
on recognising and diagnosing a problem, or on aspects of symptom intensity, levels of 
functioning, or quality of parenting, and that there was a dearth of tools that could be used in 
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routine clinical practice to cover all the important areas necessary to meaningfully rate the 
success of an intervention. In this context, the case characteristics (diagnosis, severity of 
associated disability) and case complexity (associated parental, family, medical, educational 
and social factors which may have an important influence on provision of treatment) may all 
influence the effectiveness of an intervention and so need measuring and accounting for in the 
analysis.  
Health-related Quality of Life 
The Convention on the Rights of the Child emphasised the child’s right to adequate 
circumstances for physical, mental, spiritual and social development (United Nations, 1989). 
HRQL is an important health outcome for assessing a child’s well-being, particularly when 
they are suffering from illnesses that require taking medicines. It has been increasingly used 
in adult randomised controlled trials to assess the impact of new and expensive treatments 
(Spiegelhalter et al., 1992). However, to date little attention has been given to a child’s HRQL 
outcome, with most studies focussing on treatment efficacy and safety (Clarke and Eiser, 
2004, Matza et al., 2004). In a review of HRQL assessment in paediatric oncology, only 3% 
of paediatric cancer clinical trials reported a HRQL assessment (Bradlyn et al., 1995). 
Barriers to the inclusion of a HRQL outcome have included attitudinal bias against using 
questionnaires on self-reported health, confusion as to which measure to use in a particular 
situation, the absence of a gold standard, burden and cost of assessment (Deyo and Patrick, 
1989), and the physicians lack of confidence in use of procedures for detection in the case of 
emotional disorders (Snaith, 2003). 
 
HRQL tools are multidimensional instruments designed to integrate a broad range of 
outcomes, for example, physical functioning, psychological well-being and social 
functioning. A plethora of generic and disease-specific HRQL instruments exist for use in 
adults but relatively fewer have been adapted for children (Eiser and Morse, 2001a, Harding, 
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2001). In Eiser and Morse’s (2001c) extensive review of HRQL measures used on children 
they found that in tools developed in adult populations and adapted for children, certain parts 
of several different tools might be selected, and new questions added to construct an adapted 
instrument. As we have mentioned before, this may alter the psychometric properties of the 
tool and even render it invalid or unreliable for use in the paediatric population (Clarke and 
Eiser, 2004). 
Health utility measures 
Utility measures are an alternative way of ‘summarising’ an individual’s well-being by 
allocating a single score to indicate a person’s preference for a particular health state or 
outcome (EuroQol Group, 1990, Petrou, 2003), and are used widely in health economics. 
They have been used on asthmatic children as young as 8 years using a ‘feeling thermometer’ 
(Juniper et al., 1997) and 12 years in a study of teenage survivors of extremely low birth 
weight using a standard gamble lottery approach, where the children have to choose between 
an intermediate certain health state, and a lottery ranging somewhere between perfect health 
and a least preferred state, to determine the point at which they become indifferent to getting 
the lottery or the sure thing (Feeny et al., 2004). This approach has, however, received 
criticism because of its lack of validation and inadequate conceptual basis (Carr-Hill and 
Morris, 1991). However, it does provide a different perspective on measuring health that may 
be of potential benefit to children (Petrou, 2003). 
 
In conclusion, health technologies that are used on children must demonstrate their 
effectiveness, be shown to be safe and to have limited adverse effects. They should also have 
no detrimental impact on the well-being of the child and their family. To determine the 
success of interventions, methods of outcome assessment must be accurate and reliable, be 
able to measure responsiveness to change over time within and between children, and have 
good reference data available. 
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Table 1: Main stages in the development of a health outcome measure for use with children  
Stage Issues Study design Methods of analysis 
1. Developing the instrument    
(a) Physiological Device Does this device agree sufficiently 
well with one in current use? 
Method comparison study 
 
1Mean difference, 95% limits of agreement 
2Kappa with 95% CI 
 How do I handle repeated 
measures and duplicates? 
 1ANOVA or confirmatory factor analysis 
1,2Multi-level modelling 
 How do I compare this device to a 
known gold standard? 
Diagnostic test study 1ROC curve, Area under Curve with 95% CI  
2Sensitivity, specificity, positive predicted value, 95% CI 
 
 
Problems: poor study design eg. no device calibration, time lapse between sequential measurements; insufficient control of sources of 
variability in design and/or analysis; repeated measures treated as independent observations to boost small samples 
(b) Questionnaire Creation of items Focus groups, interviews, expert review Qualitative analysis to identify themes and assess face, 
content validity 
 Do the items (eg. measured on 
Likert scale) work reasonably 
well? 
Pilot study to evaluate item performance 
on a small sample  
Mean, minimum, maximum responses; % missing; floor 
and ceiling effects; item-total correlations 
 
 
Problems: lack of use of age-appropriate language and instrument formatting; range of vocabulary available in different languages may 
affect translation and scoring; poor item performance because of cultural misunderstandings 
2. Establishing reliability and 
validity 
   
Reliability Does the instrument give stability 
and consistency of measurement? 
Intra-rater/test-retest (using the same 
assessor on two different occasions) 
Inter-rater (using 2 different assessors 
on the same occasion) 
1ICC (also mean difference, 95% limits of agreement 
may be useful)  
2Kappa, weighted kappa with 95% CI, latent class 
analysis 
 Does the instrument have good 
internal properties (reliability)?  
(for questionnaire type instruments 
typically using dichotomous items 
or Likert scales) 
Item performance evaluation on larger 
sample 
Examine internal structure and number 
of domains  
As in Stage 1 above for pilot study. 
 
Cronbach’s alpha, split-half coefficient, Kuder-
Richardson 20 method 
1,2Factor analysis, 2item-response analysis 
 Problems: Incomplete data for occasions/assessors eg. because of upset child or parent did not return for 2nd assessment; sample size too 
small for robust factor analysis/item-response analysis 
Validity Does the instrument measure what 
it is supposed to be measuring? 
Convergent/divergent validity 
Extreme groups; known-groups; 
concurrent validity using external 
criterion; predictive validity 
1Correlation (Pearson or Spearman rank) 
1T-test, Mann-Whitney U, Cuzick test for trend, 
ANOVA, Kruskal-Wallis etc.  
2Chi-squared test 
  Criterion validity (with gold standard) As in Stage 1 above for diagnostic test study 
 Problems: may not be feasible to assess all listed types of validity as may require too many assessments for a child to tolerate; no known 
gold standard criterion may be available for children 
 
3. Measuring change over time and 
discriminating between subjects 
   
Magnitude of change How do I assess the magnitude of 
change from baseline to endpoint? 
Pilot study and/or main intervention 
study  
1Cohen’s effect size, Guyatt’s responsiveness statistic, 
standard error of measurement 
 Is there a better way of taking into 
account pre-test/baseline measures 
(eg. to avoid regression to mean)? 
Randomised or non-randomised two 
group comparison on large sample 
1ANCOVA to compare groups 
2Logistic/ordinal regression 
Measurement error How do I handle measurement 
error (particularly in dietary data)? 
Take additional measurements using a 
reference instrument  
Use reference instrument (eg. diet diary, biomarker, till 
receipts) to calibrate/adjust results  
Multiple measurements How do I account for multiple 
measurements taken over time? 
 Select the baseline and most important follow up time 
point only and analyse as above; 
Use summary measures (eg. mean, peak, area under 
curve, gradient) to obtain one measure for each child; 
1,2Longitudinal data analysis, growth curve modelling 
 Problems: Establishing meaningful cut-offs and magnitudes of change that can be interpreted in different groups of children; missing data 
especially when follow up visits are necessary for sick children; use of proxy respondents and age-specific questionnaires; scaling of items 
4. Reference values for a healthy 
population 
   
Reference range How do I create reference values 
for a normal, healthy population? 
 
Take measurements from a large 
consecutive or random sample of 
children from school or community 
1Mean, 95% reference range 
or 
1Median, 2.5th and 97.5th centiles 
Gender-specific What if the measurements vary by 
gender (usually identified by a 
bimodal distribution)? 
Separate the sample measurements into 
those for boys and girls 
 
Calculate reference range for each gender group 
separately 
Age-specific What if the measurements vary for 
children of different ages? 
Separate sample measurements into age 
groups (could take quota sample); 
Use whole sample 
Calculate age-specific reference ranges for each age 
group separately  
1Linear regression, fractional polynomials 
2Logistic regression, regression splines 
Z-scores How do I measure and compare 
deviations from the average across 
different groups of children? 
 Express measurements in terms of z-score units from the 
mean (ie. reference mean for that age and gender) and 
compare summary statistics for z-scores across groups 
Anthropometric measurements Is there a way of dealing with 
variability in growth and non-
linear change eg. in weight for age, 
weight for height, BMI? 
 Z-scores, LMS (Lambda, Mu, Sigma) method (skewed 
data), GAMLSS (Generalised Additive Models for 
Location, Shape and Scale) 
 Problems: Need large samples of children from reference population; need established reference means or medians to calculate z-scores; 
more sophisticated methods (eg. LMS, GAMLSS) require specialist software 





Table 2: Biases found in the design of method comparison studies and diagnostic test studies 
 
Type of bias Reason 
Reference standard bias 
 
Use of invalid reference standard 





Verification bias Gold standard test not applied to all patients  
eg. if invasive, costly, difficult to perform 
 
Treatment paradox bias and disease 
progression bias 
Measured value alters between tests either because 
patients are treated or there is a time delay before 2nd 
test 
 
Measurement error Variability in conduct/interpretation of test 
eg.instruments not calibrated, insufficient training of 
raters 
 
Figure 1: Examples of questions that performed well (a) fitted by logistic regression (b) fitted by triple joint spline regression  
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(c) Social item ‘Spends most of time on mum’s back’  (d) Social item ‘Shy with strangers’ 
